Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02970136 · ClinicalTrials.gov registry record · NA
Increasing Uptake of Evidence-Based Screening Services Through CHW-led Multi-modality Intervention
A NA study, sponsored by University of Miami.
- Completed
- Registry status
- NA
- Development phase
- 754
- Enrollment target
NCT02970136: Completed NA study, sponsored by University of Miami.
NCT02970136 is a NA study that has completed, run by University of Miami. The registered enrollment target is 754 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (46% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02970136, a NA study, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- NA
- Development phase
- 754 participants
- Enrollment target
Study Summary
The purpose of this research study is to determine the best way to increase screening for cervical cancer, colorectal cancer, HIV, and Hepatitis C among under screened Hispanic, Haitian and African-American individuals in Hialeah, South Dade, and Little Haiti. The investigator will compare home testing led by a community health worker (CHW) versus clinic testing guided by a CHW. Community Health Workers are people who have undergone several weeks of community outreach and health education training. During the study period the participant will continue to receive all of their regular medical care from their regular health care providers. If the participant does not have a health care provider, the Community Health Workers would be able to help in referring the participant for care at a local health care clinic located in their community.
Primary Outcome
As evaluated by participant self report and completed sampling kits. Female participants are to be screened on 4 conditions: HIV, HCV, Human Papilloma Virus (HPV) and Fecal Immunochemical Testing (FIT). Male participants are to be screened on 3 conditions: HIV, Hepatitis C Virus (HCV) and FIT.
Interventions
- DEVICE OraQuick Swab
- DEVICE Fecal Immunochemical Test
- DEVICE OraQuick Fingerstick
- OTHER Standard Screening Tests
- DEVICE HPV Self-Sampling Test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 754 participants |
| Start Date | 2017-04-11 |
| Est. Completion | 2020-10-30 |
| Phase | NA |
What the finished NCT02970136 record still lists
NCT02970136 is an interventional study that assigns participants to a tested intervention. The registered 754 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (46% lower).
The record links to 0 conditions, and to 5 interventions - of which OraQuick Swab is the first listed.
NCT02970136 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02970136 about?
NCT02970136 is a clinical study titled "Increasing Uptake of Evidence-Based Screening Services Through CHW-led Multi-modality Intervention". The purpose of this research study is to determine the best way to increase screening for cervical cancer, colorectal cancer, HIV, and Hepatitis C among under screened Hispanic, Haitian and African-American individuals in Hialeah, South Dade, and Little Haiti. The investigator will compare home test...
What is the current status of trial NCT02970136?
This trial is currently completed. It is a NA study. The enrollment target is 754 participants. The study started on 2017-04-11. Estimated completion is 2020-10-30.
What interventions are being tested in trial NCT02970136?
The interventions under investigation include: OraQuick Swab (DEVICE), Fecal Immunochemical Test (DEVICE), OraQuick Fingerstick (DEVICE), Standard Screening Tests (OTHER), HPV Self-Sampling Test (DEVICE).
Who is sponsoring clinical trial NCT02970136?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02970136's enrollment target sits among peer trials
754 145th of 2000 higher than 1,856 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05379985 · 754 participants · Phase 1
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
- NCT05427370 · 754 participants · NA
The Canadian CABG or PCI in Patients With Ischemic Cardiomyopathy Trial (STICH3C)
- NCT05869149 · 756 participants · NA
Systems Science Approaches to Improve Access to Healthier Foods: The FRESH Trial
- NCT06095583 · 756 participants · Phase 3
Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI